XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,713,112 | -11.3% | 2,274,974 | 0.0% | 0.02% | -11.8% |
| Q2 2023 | $87,586,499 | +7.6% | 2,274,974 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $81,421,319 | -9.2% | 2,274,974 | 0.0% | 0.02% | -10.5% |
| Q4 2022 | $89,702,225 | +9.2% | 2,274,974 | 0.0% | 0.02% | +5.6% |
| Q3 2022 | $82,127,000 | +18.7% | 2,274,974 | 0.0% | 0.02% | +20.0% |
| Q2 2022 | $69,205,000 | -0.5% | 2,274,974 | 0.0% | 0.02% | +25.0% |
| Q1 2022 | $69,546,000 | -2.1% | 2,274,974 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $71,070,000 | +382.7% | 2,274,974 | +136.1% | 0.01% | +266.7% |
| Q3 2021 | $14,722,000 | -17.9% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,940,000 | +4.0% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,247,000 | +16.4% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,819,000 | +38.9% | 963,500 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $10,666,000 | -11.7% | 963,500 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $12,082,000 | +10.6% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,926,000 | -13.5% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,631,000 | +45.5% | 963,500 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $8,681,000 | -8.6% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,500,000 | -3.0% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,789,000 | +61.0% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,080,000 | -52.2% | 963,500 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $12,718,000 | -3.3% | 963,500 | -32.6% | 0.00% | 0.0% |
| Q2 2018 | $13,147,000 | +87.8% | 1,429,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $7,002,000 | +73.4% | 1,429,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $4,037,000 | -4.2% | 1,429,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $4,216,000 | -6.3% | 1,429,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,501,000 | -21.3% | 1,429,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,716,000 | -39.4% | 1,429,000 | +16.7% | 0.00% | -50.0% |
| Q4 2016 | $9,433,000 | +13.1% | 1,225,000 | +18.9% | 0.00% | 0.0% |
| Q3 2016 | $8,343,000 | +36.8% | 1,030,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $6,098,000 | -15.3% | 1,030,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $7,200,000 | -13.1% | 1,030,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,281,000 | -2.7% | 1,030,000 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $8,508,000 | +11.9% | 1,030,000 | +56.2% | 0.00% | +50.0% |
| Q2 2015 | $7,604,000 | -31.6% | 659,497 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $11,122,000 | -5.2% | 659,497 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $11,732,000 | – | 659,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |